Legal News Articles - Drugs/Medical
March 6, 2017. By Gordon Gibb.
Parsippany, NJ: This could evolve to a compelling year for Japanese-based pharmaceutical giant Daiichi Sankyo following the expiry of its patent exclusivity for Benicar last year and a corresponding drop in revenue for a product characterized as its global mainstay. As generics for olmesartan (Benicar) continue to gain market share in 2017, coupled with a growing number of Benicar lawsuits which number around 1,700 and climbing, industry watchers will be monitoring Daiichi in the coming months and years to see how the corporation responds, and what effect that may have on consumers.Read [ Revenues Drop While Lawsuits Rise over Benicar for Daiichi Sankyo ]
March 5, 2017. By Brenda Craig.
Seattle, WA It’s almost a century since two Canadian researchers discovered insulin could save the lives of diabetics. They believed that no one should profit from their remarkable discovery and sold the patent to the University of Toronto for $1. Changes to the production of insulin and expiring patents have changed all that. Today, insulin is big business.Read [ Fighting Back Against the High Cost of Insulin ]
March 4, 2017. By Jane Mundy.
Miami Beach, FL: A former arms dealer who made the news ten years ago and again last year when the film “War Dogs” was released is making headlines again, this time claiming that Abilify caused his compulsive behaviors.Read [ Abilify Makes Headlines ]
March 4, 2017. By Gordon Gibb.
New Orleans, LA: As important as it is to be aware of any, and all side effects associated with a drug such as Taxotere, patients in need of the chemotherapy drug are already coming from a position of significant physical and emotional challenge: the fallout from a cancer diagnosis. And while most cancer patients are aware that hair loss is a common byproduct of chemotherapy and cancer treatments, many would not be cognizant about the potential for Taxotere hair loss to be permanent.Read [ Potential for Permanent Taxotere Hair Loss Not Widely Promoted ]
March 3, 2017. By Brenda Craig.
Dallas, TX A Dallas doctor decided in 2009 to blow the whistle on a physician over a billing scam that was costing the healthcare system and American taxpayers millions and millions of dollars. Six years later, after a long investigation by the Department of Justice (DOJ), Dr. Bijan Oughatiyan’s former employer, IPC Healthcare Inc., was ordered to pay $60 million plus interest, to settle a false claims case brought against the company based on the information the whistleblower doctor provided.Read [ Doctor from Dallas Collects $11.4 million for Blowing the Whistle on Healthcare Fraud ]
March 3, 2017. By Lucy Campbell.
Santa Clara, CA: The first bellwether Fresenius trial for people who opted out of the earlier $250 million dollar settlement has failed to make its case, with the jury finding in favor of Fresenius Medical Care.Read [ Granuflo Bellwether Case Fails to Prove Fault ]
March 1, 2017. By Gordon Gibb.
Washington, DC: It’s little wonder, given the aging of the largest single segment of the American population, that medical device manufacturers continue to jockey for additional market share while attempting to protect their existing slice of the pie. To that end, plaintiffs in hip replacement failure lawsuits assert that manufacturers knowingly marketed and promoted defective hip implants they knew were flawed.Read [ Defective Hip Implants: Newer Isn’t Always Better ]
March 1, 2017. By Jane Mundy.
San Diego, CA: Just over a year from now the first Ethicon surgical abdominal mesh lawsuit is slated for trial. According to a recent study published in JAMA, there could be many more reports of hernia complications—and abdominal mesh lawsuits—before Ethicon’s Physiomesh trial.Read [ First Physiomesh Hernia Mesh Lawsuit Slated for Trial – and More Mesh Complications ]
March 1, 2017. By Gordon Gibb.
New Orleans, LA: It could be mere co-incidence, but on the eve of the National Basketball Association (NBA) All Star Game that served to delay Xarelto bellwether trials by a month, the manufacturers of Xarelto chose to highlight an aging NBA all-star player who expounds upon the virtues of rivaroxaban (Xarelto) and professes to use it himself. As such, a visit to the official Xarelto website showcases the former All-American player, rather than the potential for a Xarelto bleeding issue.Read [ Plaintiffs Looking for a Slam Dunk in First Xarelto Bellwether Trial This Month ]
February 28, 2017. By Jane Mundy.
Toronto, ONT: Boston Scientific is the first of several transvaginal mesh manufacturers to face a certified contested action concerning transvaginal meshes in Canada.Read [ Canadian Transvaginal Mesh Class Action ]
- Eliquis Lawsuits Moving Forward in MDL, Venue Still to be Determined By Gordon Gibb (Feb-27-17)
- Essure or Hysterectomy—the Latter May Be Preferable By Jane Mundy (Feb-27-17)
- Number of Taxotere MDL Lawsuits Surpasses 700 Cases By Deb Hipp (Feb-27-17)
- While FDA Suggests Potential for Testosterone Abuse, Health Canada Takes a Pass By Gordon Gibb (Feb-26-17)
- IVC Filter Recipient Walking Time Bomb? By Jane Mundy (Feb-25-17)
- Implanon Reviews Could Steer Women Away From the Birth Control Device By Deb Hipp (Feb-24-17)
- Talcum Powder Ovarian Cancer Whistleblower By Jane Mundy (Feb-21-17)
- Risperdal Case Load Shows No Sign of Slowing Down By Gordon Gibb (Feb-21-17)
- Government Agencies Release Recommended Warning for Labeling Drug Products Associated with Stevens-Johnson Syndrome By Deb Hipp (Feb-19-17)
- Blogger Says ‘No Thanks’ to IVC Filter By Gordon Gibb (Feb-19-17)
- Stockert 3T Heater-Cooler System Confusion and Concern By Jane Mundy (Feb-19-17)
- Qui Tam Whistleblowers and Healthcare Fraud: “It’s a Completely Criminal Enterprise” By Jane Mundy (Feb-19-17)
- Plaintiff Claims C-Qur Mesh Biologically Incompatible with Human Tissue By Gordon Gibb (Feb-19-17)
- Nurse Lives with Bard IVC Filter tine lost in her Body By Brenda Craig (Feb-16-17)
- Taxotere Hair Loss Lawsuits Moving Forward in MDL By Gordon Gibb (Feb-15-17)
- Young Mother Recounts Horrid Experience with Birth Control Implant By Gordon Gibb (Feb-15-17)
- Endoscope Disinfection Problems Extend Beyond Devices Themselves By Gordon Gibb (Feb-14-17)
- Federal Judge Dismisses Bravelle Lawsuit in Unusual Removal Situation By Deb Hipp (Feb-14-17)
- Mesothelioma Victim Washed Late Husband’s Work Clothes By Gordon Gibb (Feb-13-17)
- Former Propecia Users May Have Underlying Neurobiological Abnormalities By Deb Hipp (Feb-13-17)
- US Food and Drug Administration, FDA, St. Jude Medical Inc. By Gordon Gibb (Feb-12-17)
- Appeals: I’ve had a Few, but then Too Few to Mention? By Gordon Gibb (Feb-10-17)
- Canadian Study Finds 12 Percent of ADHD Youth Prescribed Antipsychotic Drugs Such as Risperdal By Deb Hipp (Feb-10-17)
- Surgery Patients Demand Monitoring for Potentially Deadly Infection in Class Action By Brenda Craig (Feb-9-17)
- Damning Report on FDA Approval of Power Morcellators Released By Lucy Campbell (Feb-9-17)
- New Talcum Powder Cancer Lawsuit Against Johnson & Johnson Filed By Multiple Plaintiffs By Deb Hipp (Feb-9-17)
- Federal Bair Hugger Lawsuits Climbing, Now Number 1105 in MDL By Gordon Gibb (Feb-8-17)
- Latest Defective Catheter Takes Its Place in Long Line of FDA Recalls By Deb Hipp (Feb-8-17)
- Invokana Still Invoking Concerns By Gordon Gibb (Feb-8-17)
- INRatio Class Action Headed for Trial By Brenda Craig (Feb-7-17)
- Benicar Side Effects Lawsuit Blocked from Remand to State Court By Gordon Gibb (Feb-7-17)
- Do Medication Guides for PPI Kidney Disease and Prevacid Lack Consistency? By Gordon Gibb (Feb-6-17)
- Hernia Mesh Implants: Risks Outweigh Benefits By Jane Mundy (Feb-5-17)
- Smith & Nephew Hip Implant Lawsuits Headed to Multidistrict Litigation By Deb Hipp (Feb-4-17)
- Monsanto Loses Labelling Battle in California – Tentatively By Brenda Craig (Feb-3-17)
- Xarelto Bellwether Pushed Back by NBA All-Star Game By Gordon Gibb (Feb-3-17)
- Abilify Addiction: Age no Barrier By Jane Mundy (Feb-3-17)
- New Study Suggests IVC Filters are Overused By Heidi Turner (Jan-30-17)
- Why Take Lyrica and Other Anticonvulsant Drugs Associated with Birth Defects? By Jane Mundy (Jan-30-17)
- Risperdal Litigation Second Largest By Jane Mundy (Jan-29-17)